Effective Attenuation of Arteriosclerosis Following Lymphatic-Targeted Delivery of Hyaluronic Acid-Decorated Rapamycin Liposomes

BACKGROUND: The activation of lymphatic vessel function is the crux to resolving atherosclerosis (AS), a chronic inflammatory disease. Rapamycin (RAPA) recently has attracted considerable attention as a potent drug to induce atherosclerotic plaque attenuation. The objective of this work was to devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaojia, Lin, Caiyan, Zhong, Wenfei, Yuan, Zhongwen, Yan, Pengke, Guan, Shixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404413/
https://www.ncbi.nlm.nih.gov/pubmed/37551276
http://dx.doi.org/10.2147/IJN.S410653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404413/
https://www.ncbi.nlm.nih.gov/pubmed/37551276
http://dx.doi.org/10.2147/IJN.S410653

Ejemplares similares